과제정보
This research was supported by a research grant from the Fire Fighting Safety & 119 Rescue Technology Research and Development Program funded by National Fire Agency (grant number: MPSS-FireSafety-2015-80), a research grant from the Korea Centers for Disease Control & Prevention (grant number: 2018ER630200).
참고문헌
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71:e127-248. https://doi.org/10.1016/j.jacc.2017.11.006
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021-104. https://doi.org/10.1093/eurheartj/ehy339
- Kim KI, Ihm SH, Kim GH, et al. 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens 2019;25:19. https://doi.org/10.1186/s40885-019-0123-y
- Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202:1028-34. https://doi.org/10.1001/jama.1967.03130240070013
- Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970;213:1143-52.
- Hypertension-Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974;229:409-18. https://doi.org/10.1001/jama.1974.03230420021019
- Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-71. https://doi.org/10.1001/jama.1979.03300230018021
- The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1980;315:1261-7. https://doi.org/10.1016/S0140-6736(80)91730-4
- Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. Br Med J (Clin Res Ed) 1985;291:97-104. https://doi.org/10.1136/bmj.291.6488.97
- Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:1755-62. https://doi.org/10.1016/S0140-6736(98)04311-6
- Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994;330:877-84. https://doi.org/10.1056/NEJM199403313301301
- Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. https://doi.org/10.1001/jama.289.19.2560
- ACCORD Study Group, Cushman WC, Evans GW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-85. https://doi.org/10.1056/NEJMoa1001286
- Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002;288:2421-31. https://doi.org/10.1001/jama.288.19.2421
- Ruggenenti P, Perna A, Loriga G, et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 2005;365:939-46. https://doi.org/10.1016/S0140-6736(05)71082-5
- Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. https://doi.org/10.1001/jama.2013.284427
- SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-16. https://doi.org/10.1056/NEJMoa1511939
- Pappaccogli M, Di Monaco S, Perlo E, et al. Comparison of automated office blood pressure with office and out-off-office measurement techniques. Hypertension 2019;73:481-90. https://doi.org/10.1161/HYPERTENSIONAHA.118.12079
- Roerecke M, Kaczorowski J, Myers MG, et al. Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: a systematic review and meta-analysis. JAMA Intern Med 2019;179:351-62. https://doi.org/10.1001/jamainternmed.2018.6551
- Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957-67. https://doi.org/10.1016/S0140-6736(15)01225-8
- Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016;387:435-43. https://doi.org/10.1016/S0140-6736(15)00805-3
- Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens 2016;34:613-22. https://doi.org/10.1097/HJH.0000000000000881
- Lee CJ, Ryu J, Kim HC, et al. Clinical benefit of treatment of stage-1, low-risk hypertension. Hypertension 2018;72:1285-93. https://doi.org/10.1161/HYPERTENSIONAHA.118.11787
- SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64. https://doi.org/10.1001/jama.1991.03460240051027
- Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64. https://doi.org/10.1016/S0140-6736(97)05381-6
- Wang JG, Staessen JA, Gong L, Liu L; Systolic Hypertension in China (Syst-China) Collaborative Group. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med 2000;160:211-20. https://doi.org/10.1001/archinte.160.2.211
- Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98. https://doi.org/10.1056/NEJMoa0801369
- JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008;31:2115-27. https://doi.org/10.1291/hypres.31.2115
- Ogihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010;56:196-202. https://doi.org/10.1161/HYPERTENSIONAHA.109.146035
- Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA 2016;315:2673-82. https://doi.org/10.1001/jama.2016.7050
- Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006;144:884-93. https://doi.org/10.7326/0003-4819-144-12-200606200-00005
- Bohm M, Schumacher H, Teo KK, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet 2017;389:2226-37. https://doi.org/10.1016/S0140-6736(17)30754-7
- Kimm H, Mok Y, Lee SJ, Lee S, Back JH, Jee SH. The J-curve between diastolic blood pressure and risk of all-cause and cardiovascular death. Korean Circ J 2018;48:36-47. https://doi.org/10.4070/kcj.2017.0036
- Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials. J Hypertens 2016;34:1451-63. https://doi.org/10.1097/HJH.0000000000000972
- Bansilal S, Castellano JM, Garrido E, et al. Assessing the impact of medication adherence on long-term cardiovascular outcomes. J Am Coll Cardiol 2016;68:789-801. https://doi.org/10.1016/j.jacc.2016.06.005